Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

HIV antiretroviral therapy treatment soon will become a whole lot simpler than most antibiotic regimens when the FDA approves the combination pill of efavirenz/emtricitabine/ tenofovir (Truvada/Sustiva).

New Once-a-Day Pill Submitted to FDA